News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb
Universal Ibogaine
Silo Wellness Announces Corporate Updates
Silo Wellness
COMPASS Pathways to Launch Phase II Trial of COMP360 Psilocybin Therapy For Post-Traumatic Stress Disorder
Compass Pathways
PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch
Revive Therapeutics
Pharmather
PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch
Pharmather
Revive Therapeutics
Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion Technology to Traditional Medicine Ingredients
Mydecine Innovations Group
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Fibromyalgia
Tryp Therapeutics
Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial
Braxia Scientific Corp.
U.S. FDA Approves Nova Mentis Orphan Drug Application
Nova Mentis Life Science
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET
Field Trip Health
PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics
Pharmather
PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market in Germany
Pharmadrug Inc.
Red Light Holland Appoints New Chief Financial Officer
Red Light Holland
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.